Search

everythinglearnresearchcommunity

for

Search:↓

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

Rapamycin-primed exosomes can significantly boost hair regrowth.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Minoxidil may promote hair growth by mimicking a natural body chemical.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Ruxolitinib can help regrow hair in severe alopecia areata.

Minoxidil sulfate relaxes blood vessels by increasing potassium permeability.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

GnRH treatment can reduce breast cancer cell invasion.

Minoxidil may promote hair growth by mimicking a natural body process.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

A woman had a skin reaction from a cough suppressant, dextromethorphan, which is a new cause of fixed-drug eruption.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.